However, the recanalization of major vessels with IV-tPA/ET does not ensure adequate microvascular perfusion and recovery of tissue damage due to the associated risk of the “no-reflow” phenomenon that is exacerbated under stroke-related comorbidities such as aging, diabetes, or hypertension. The gene discussed is PLAT; the disease is Stroke.